nav-left cat-right
cat-right

nanoMR, Stratos Partner on Pathogen Detection

Stratos Product Development is teaming up with pathogen detection firm nanoMR to develop instrumentation for the latter’s Pathogen Capture System (PCS). The platform uses an immunomagnetic capture process to isolate rare cell types including bacterial and fungal pathogens directly from blood or other samples for further phenotypic or molecular analysis. The system can target multiple cell types simultaneously, or...

Accelr8, Denver Health Win $2M to Develop Battlefi...

Accelr8 and Denver Health received notification that the Defence Medical Research and Development Program (DMRPD) has recommended a $2 million award to support a three-year project focused on developing a rapid diagnostic system for wound infections and serious infections secondary to trauma. The project was the sole recipient of funds under the Military Infectious Diseases Applied Research Award (MID-ARA) initiative...

Device sought for early screening

By Carly Harrington Posted April 15, 2012 at 4 a.m. Every year when it’s time for her routine physical exam, Nancy Munro’s family practice physician will place electrodes to her chest and run an electrocardiogram to check the health of her heart. The simple, low-cost EKG test, which records the electrical activity of a person’s heart, takes a matter of seconds and gives her doctor something to look...

RiboMed Launches Improved Prognostic Multi Biomark...

RiboMed Clinical Services Laboratory (RCSL), a CLIA-certified subsidiary of RiboMed Biotechnologies, today announced the release of a multi-marker methylation prognostic test for grading gliomas, the most common type of brain cancer. The test robustly analyzes 8 genes for differential methylation on FFPE (Formalin Fixed Paraffin Embedded) tumor samples to determine the G-CIMP (Glioma CpG Island Methylation Phenotype) score....

BNC Collaborators Author High-profile Paper in Nat...

London, UK – 17 October 2008: Research by scientists collaborating with specialist product development consultancy, Bio Nano Consulting (BNC), into the workings of vancomycin – one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA – has been published in Nature Nanotechnology (October 2008). The researchers, led by Dr Rachel McKendry and Professor Gabriel...
Page 2 of 212